相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carbon-Based Materials in Photodynamic and Photothermal Therapies Applied to Tumor Destruction
Karina J. Lagos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Regulatory T cells: A review of manufacturing and clinical utility
Tewodros Mamo et al.
TRANSFUSION (2022)
Utilization of Treg Cells in Solid Organ Transplantation
Tanya Juneja et al.
FRONTIERS IN IMMUNOLOGY (2022)
A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy
Esther Bernaldo-de-Quiros et al.
FRONTIERS IN IMMUNOLOGY (2022)
A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
Jennifer S. Whangbo et al.
BLOOD ADVANCES (2022)
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote transplantation tolerance in humans
Tiong Yeng Lim et al.
JOURNAL OF HEPATOLOGY (2022)
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans
Qizhi Tang et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
Veerle Ide et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
Margaret L. MacMillan et al.
BLOOD ADVANCES (2021)
Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance
Toshihito Hirai et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells
Linda M. Lee et al.
FRONTIERS IN IMMUNOLOGY (2021)
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with 1 diabetes
Shen Dong et al.
JCI INSIGHT (2021)
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation
Alberto Sanchez-Fueyo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Regulatory T Cells and Human Disease
Shimon Sakaguchi et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Engineered IL-2 Cytokine-Cytokine Receptor Complex Enables Selective Expansion of Regulatory T Cells and Facilitates Establishment of Organ Transplantation Tolerance
Toshihito Hirai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A Clinical Trial With Adoptive Transfer of Ex Vivo-induced, Donor-specific Immune-regulatory Cells in Kidney Transplantation-A Second Report
Ichiro Koyama et al.
TRANSPLANTATION (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
In situ recruitment of regulatory T cells promotes donor-specific tolerance in vascularized composite allotransplantation
James D. Fisher et al.
SCIENCE ADVANCES (2020)
The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations
Lauren V. Terry et al.
FRONTIERS IN IMMUNOLOGY (2020)
Regulatory T cells in solid organ transplantation
Muhammad Atif et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
T-reg cell-based therapies: challenges and perspectives
Caroline Raffin et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Methods to manufacture regulatory T cells for cell therapy
K. N. MacDonald et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Therapeutic use of regulatory T cells for graft-versus-host disease
Shlomo Elias et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
mTOR Inhibitor Everolimus in Regulatory T Cell Expansion for Clinical Application in Transplantation
Roberto Gedaly et al.
TRANSPLANTATION (2019)
Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System
Jose Manuel Marin Morales et al.
FRONTIERS IN IMMUNOLOGY (2019)
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease
Jennifer S. Whangbo et al.
BLOOD ADVANCES (2019)
Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism
Joseph R. Leventhal et al.
HUMAN IMMUNOLOGY (2018)
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
Federica Barzaghi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
Jonathan T. Sockolosky et al.
SCIENCE (2018)
A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Cell Therapy in Organ Transplantation: Our experience on the Clinical Translation of Regulatory T Cells
Niloufar Safinia et al.
FRONTIERS IN IMMUNOLOGY (2018)
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
Anke Fuchs et al.
FRONTIERS IN IMMUNOLOGY (2018)
A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials
Henrieta Fraser et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Ex vivo generation of umbilical cord blood T regulatory cells expressing the homing markers CD62L and cutaneous lymphocyte antigen
Joshua N. Kellner et al.
Oncotarget (2018)
Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance
James M. Mathew et al.
SCIENTIFIC REPORTS (2018)
Revisiting IL-2: Biology and therapeutic prospects
Abul K. Abbas et al.
SCIENCE IMMUNOLOGY (2018)
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis
Caroline J. Voskens et al.
INFLAMMATORY BOWEL DISEASES (2017)
Transplant trials with Tregs: perils and promises
Qizhi Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Treg therapy in transplantation: a general overview
Marco Romano et al.
TRANSPLANT INTERNATIONAL (2017)
Good Manufacturing Practice-compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients With Autoimmune and Inflammatory Disorders
Manuel Wiesinger et al.
FRONTIERS IN IMMUNOLOGY (2017)
Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells
Xuehui He et al.
SCIENTIFIC REPORTS (2017)
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
S. Chandran et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials
David H. Mckenna et al.
CYTOTHERAPY (2017)
Discarded Human Thymus Is a Novel Source of Stable and Long-Lived Therapeutic Regulatory T Cells
I. E. Dijke et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
Claudio G. Brunstein et al.
BLOOD (2016)
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B. Canavan et al.
GUT (2016)
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapy
Abdullah Alsuliman et al.
CYTOTHERAPY (2016)
A Pilot Study of Operational Tolerance With a Regulatory T-cell-Based Cell Therapy in Living Donor Liver Transplantation
Satoru Todo et al.
HEPATOLOGY (2016)
An essential role for the IL-2 receptor in Treg cell function
Takatoshi Chinen et al.
NATURE IMMUNOLOGY (2016)
Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders
Karolina Golab et al.
ONCOTARGET (2016)
Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
Niloufar Safinia et al.
ONCOTARGET (2016)
Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease
Anke Theil et al.
CYTOTHERAPY (2015)
Regulatory T Cells Require TCR Signaling for Their Suppressive Function
Amanda M. Schmidt et al.
JOURNAL OF IMMUNOLOGY (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Regulatory T cells: serious contenders in the promise for immunological tolerance in transplantation
Niloufar Safinia et al.
FRONTIERS IN IMMUNOLOGY (2015)
Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo
Simrit Parmar et al.
BLOOD (2015)
Ultra Low-Dose IL-2 for GVHD Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation Mediates Expansion of Regulatory T Cells without Diminishing Antiviral and Antileukemic Activity
Alana A. Kennedy-Nasser et al.
CLINICAL CANCER RESEARCH (2014)
Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell Pool
J. Christoph Vahl et al.
IMMUNITY (2014)
Continuous requirement for the TCR in regulatory T cell function
Andrew G. Levine et al.
NATURE IMMUNOLOGY (2014)
Ex Vivo Expanded Human Regulatory T Cells Delay Islet Allograft Rejection via Inhibiting Islet-Derived Monocyte Chemoattractant Protein-1 Production in CD34+ Stem Cells-Reconstituted NOD-scid IL2rγnull Mice
Fang Xiao et al.
PLOS ONE (2014)
Clinical Grade Manufacturing of Human Alloantigen-Reactive Regulatory T Cells for Use in Transplantation
A. L. Putnam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Regulatory T cells: recommendations to simplify the nomenclature
Abul K. Abbas et al.
NATURE IMMUNOLOGY (2013)
Donor-specific Regulatory T Cells Generated on Donor B Cells Are Superior to CD4+CD25high Cells in Controlling Alloimmune Responses in Humanized Mice
F. Noyan et al.
TRANSPLANTATION PROCEEDINGS (2013)
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
Agnes Hartemann et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Bioinspired Controlled Release of CCL22 Recruits Regulatory T Cells In Vivo
Siddharth Jhunjhunwala et al.
ADVANCED MATERIALS (2012)
Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children
Natalia Marek-Trzonkowska et al.
DIABETES CARE (2012)
Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells
Siddharth Jhunjhunwala et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model
Haruei Ogino et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application
Sya N. Ukena et al.
PLOS ONE (2012)
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
Claudio G. Brunstein et al.
BLOOD (2011)
Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys
Anlun Ma et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
John Koreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity
Keli L. Hippen et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Human Regulatory T Cells with Alloantigen Specificity Are More Potent Inhibitors of Alloimmune Skin Graft Damage than Polyclonal Regulatory T Cells
Pervinder Sagoo et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Long-Term Follow-Up of Recipients of Combined Human Leukocyte Antigen-Matched Bone Marrow and Kidney Transplantation for Multiple Myeloma With End-Stage Renal Disease
Thomas R. Spitzer et al.
TRANSPLANTATION (2011)
Mammalian Target of Rapamycin Inhibition and Alloantigen-Specific Regulatory T Cells Synergize To Promote Long-Term Graft Survival in Immunocompetent Recipients
Giorgio Raimondi et al.
JOURNAL OF IMMUNOLOGY (2010)
In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
Satish N. Nadig et al.
NATURE MEDICINE (2010)
Ex Vivo-Expanded Human Regulatory T Cells Prevent the Rejection of Skin Allografts in a Humanized Mouse Model
Fadi Issa et al.
TRANSPLANTATION (2010)
Rapamycin Promotes the Expansion of CD4+ Foxp3+ Regulatory T Cells After Liver Transplantation
L. Lu et al.
TRANSPLANTATION PROCEEDINGS (2010)
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells
Piotr Trzonkowski et al.
CLINICAL IMMUNOLOGY (2009)
Impact of the TCR Signal on Regulatory T Cell Homeostasis, Function, and Trafficking
Joong Kyu Kim et al.
PLOS ONE (2009)
Ex vivo-expanded natural CD4+CD25+ regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts
G. Xia et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice
Julia Yuen-Shan Tsang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
CD28 costimulation is essential for human T regulatory expansion and function
Tatiana N. Golovina et al.
JOURNAL OF IMMUNOLOGY (2008)
Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127pos Depletion, Treg Expansion, and Treg Cryopreservation
Jorieke H. Peters et al.
PLOS ONE (2008)
Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2
Andreas A. Hombach et al.
JOURNAL OF IMMUNOLOGY (2007)
Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules
Megan M. Suhoski et al.
MOLECULAR THERAPY (2007)
Foxp3-dependent programme of regulatory T-cell differentiation
Marc A. Gavin et al.
NATURE (2007)
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance
Dela Golshayan et al.
BLOOD (2007)
Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients
Manuela Battaglia et al.
JOURNAL OF IMMUNOLOGY (2006)
Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
Ming O. Li et al.
IMMUNITY (2006)
Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity
David G. Wichlan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Isolation of CD4+CD25+ regulatory T cells for clinical trials
P Hoffmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Specificity of CD4(+)CD25(+) regulatory T cell function in alloimmunity
A Sanchez-Fueyo et al.
JOURNAL OF IMMUNOLOGY (2006)
Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates
H Bashuda et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Regulatory T cell lineage specification by the forkhead transcription factor FoxP3
JD Fontenot et al.
IMMUNITY (2005)
CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2
XG Tai et al.
NATURE IMMUNOLOGY (2005)
Ex vivo selection of recipient-type alloantigen-specific CD4+CD25+ immunoregulatory T cells for the control of graft-versus-host disease after allogeneic hematopoietic stem-cell transplantation
A Trenado et al.
TRANSPLANTATION (2004)
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes
QZ Tang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation
M Edinger et al.
NATURE MEDICINE (2003)
Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist
CH Lin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Recipient-type specific CD4(+)CD25(+) regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia
A Trenado et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease
JL Cohen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation
P Hoffmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality
PA Taylor et al.
BLOOD (2002)
CD4+CD25high regulatory cells in human peripheral blood
C Baecher-Allan et al.
JOURNAL OF IMMUNOLOGY (2001)
Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood
D Dieckmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
CL Bennett et al.
NATURE GENETICS (2001)
分享论文
